Silence Therapeutics reported $23.68M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
AstraZeneca USD 16.69B 5.74B Sep/2025
Autolus Therapeutics Ltd USD 82.61M 8.39M Jun/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Novartis USD 9.86B 115M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 23.68M 4.76M Sep/2024